Back to WA Weiss Asset Management LP

Position history for WAWeiss Asset Management LP's holdings in Bridgebio Pharma Inc Note 2.500percent 3/1

No. Weiss Asset Management exited its Bridgebio Pharma Inc Note 2.500percent 3/1 position in Q1 2026. Its Q4 2025 13F listed 50,624,000 shares worth $95.6M. Weiss Asset Management first reported Bridgebio Pharma Inc Note 2.500percent 3/1 in Q1 2023 and held it in 11 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$34.8M

Total Shares Change

-33.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%—
0
2025-Q4
Decreased
50.6M
-25.1%
$95.6M1.3%—
0
2025-Q3
Unchanged
67.6M
0.0%
$94.9M1.1%—
0
2025-Q2
Decreased
67.6M
-1.4%
$84.6M1.0%—
0
2025-Q1
Increased
68.6M
+107.3%
$78.4M1.6%—
76
2024-Q4
Decreased
33.1M
-38.3%
$34.8M0.7%—
0

Optional analytics helps us improve. How it’s used